There are scarce data regarding the relationship between insulin resistance, parathyroid hormone (PTH) and blood pressure (BP) in the literature. This study is aimed to investigate the interrelationships between BPs, insulin resistance and PTH levels in never treated newly diagnosed essential hypertensive patients.
INTRODUCTION
It is well known that insulin resistance is highly prevalent in essential hypertensive patients and related with cardiovascular morbidity (1, 2) . Recent evidence also suggests that serum parathyroid hormone (PTH) levels were related with increased blood pressure (BP) (3) (4) (5) . Apart from increased BP, PTH levels were shown to be associated with insulin resistance (6, 7) . Although the aforementioned knowledge exists, scarce data are present regarding the relationship between PTH, insulin resistance, and hypertension in the literature. Thus the current study aimed to analyze the relationship between PTH, BPs and insulin resistance in never treated essential hypertensive patients with various levels of kidney function.
MATERIALS and METHODS
The current study was conducted in the outpatient nephrology unit in a secondary state Hospital between August 2010 and January 2012. The study was in accordance with the declaration of Helsinki and local ethical approval and informed consent was obtained before enrolment. The study population consisted of patients with newly diagnosed hypertensive that was hitherto treated. All patients underwent the following procedures: history taking, physical examination, 12 lead electrocardiographic evaluation, routine urine analysis, fasting blood samples for biochemical analysis (including measurement of insulin, PTH and thyroid function tests), 24-hour urine collection to measure urinary protein excretion and creatinine clearance. An information leafl et along with a urine container was given to all subjects and they also received a verbal explanation about how to collect a proper 24-hour urine sample. After excluding the fi rst morning urine sample of the collection day, urine was collected over 24 h, which included the fi rst urine sample of the next morning. During the sampling period, subjects were instructed to keep urine samples in a dark and cool place. At the end of the collection period, the urine containers were taken to the laboratory within 2-4 h. Since erroneous estimations of salt intake may occur according to problems in collecting 24-h urine samples participants with urinary creatinine out of reference levels (reference intervals for 24-hour urinary creatinine were accepted as 10.7 -26.0 g/kg for women and 12.1 -28.9 g/kg for men) were excluded (8) . Patients with diabetes mellitus, coronary artery disease, heart failure, rhythm problems, nephrotic syndrome, urinary tract infection were excluded. None of the patients reported any alcohol intake. 
Blood Pressure Measurement
Seated clinic BP was measured manually with a mercury column sphygmomanometer and an appropriate size cuff after 5 minutes of rest according to AHA guidelines. Hypertension was defi ned as systolic blood pressure between ≥140 mmHg and/or Diastolic BP ³90 mmHg (9) .
Laboratory Analysis
The routine laboratory parameters were measured after 10-12 hours of fasting. The laboratory parameters including fasting blood glucose, urea, creatinine, uric acid, sodium, potassium, hemoglobin, albumin, calcium, phosphorus, total cholesterol, low density lipoprotein cholesterol (LDL-cholesterol) high density lipoprotein cholesterol (HDL-cholesterol), triglycerides, thyroid stimulating hormone (TSH), Free triiodothyronine (FT3), Free thyroxine (FT4), insulin and PTH levels.
Statistics
Statistical analysis was performed using SPSS 15.0 (SPSS Inc, Evanston, Illinois, USA). Results were considered statistically signifi cant if two-tailed P value was less than 0.05. Data was checked for normality. Data was shown as mean±standard deviation. For correlations of normally and non-normally distributed parameters Pearson's correlation coeffi cient r and Spearman's correlation coeffi cient rho was used respectively. The Kruskal Wallis Test was used for the comparison of PTH and HOMA-INDEX among 3 groups (isolated systolic hypertension, isolated diastolic hypertension and both systolic and diastolic hypertension).
RESULTS
Initially 128 patients were enrolled. Two patient with coronary artery disease, 1 patients with heart failure, 3 patients with diabetes, 2 patients with nephrotic syndrome, 2 patients with atrial fi brillation, 4 patients with urinary tract infection, 5 patients with sub-clinic and overt hypothyroidism, 3 patients (Figure 1 ). There was no correlation between PTH and systolic BP. Spearman correlation analysis revealed that diastolic BP was correlated with fasting blood glucose (rho: 0.220, p: 0.035), and PTH levels (rho: 0.235, p: 0.024). There was no correlation between diastolic BP with HOMA-INDEX. Additionally PTH levels were correlated with calcium (rho: -0.234, p: 0.028), with subclinical hyperthyroidism, 1 patient with renal artery stenosis, 5 patients who did not want to participate and 8 patients with incomplete 24-hour urine calculation were excluded from the study. The fi nal patient population consisted of never treated 92 newly diagnosed hypertensive patients. The demographic and laboratory parameters of the patients were shown in Table I .
Spearman correlation analysis revealed that systolic BP was correlated with diastolic BP (rho: 0.337, p: 0.001), age (rho: 0.214, p: 0.041) BMI (rho: 0.325, p: 0.004), blood urea nitrogen range; nevertheless a signifi cant increase in blood pressure was seen (3) . Of note in the current study we did not show any association between calcium, systolic BP and diastolic BP.
We did not demonstrate any association between PTH levels and insulin resistance in the present study. In the literature there are contrasting fi ndings about this issue. While some studies showed association (6, 22) ; others did not show any relationship (23) . Besides some studies have shown that the insulin resistance was not changed in patients before and after parathyroidectomy (24, 25) . We do not know the causes of these discrete fi ndings but patient characteristics, co-morbidities and study design may be responsible
One of the interesting fi nding is HOMA-INDEX is only correlated with systolic BP, where as PTH levels were only correlated with diastolic BP. We cannot make any speculations about this situation. However the literature contains studies in which the discrepancy between systolic and diastolic BP was observed. Adler et al. (26) found an association between systolic BP and microvascular and macrovascular complications in type 2 diabetic patients. In another study, 24-h average systolic BP or pulse pressure values were second only to age in their correlation with carotid artery wall status; whereas 24-h average diastolic BP had no effect (27) . The discrepancy between systolic and diastolic BPs regarding insulin resistance and PTH levels must be evaluated by further studies.
This study has limitations. The standard methods for quantifying insulin sensitivity are hyperinsulinemic euglycemic glucose clamp and the intravenous glucose tolerance test [28). As these methods are impractical in clinical practice and are diffi cult to perform in epidemiological research, we instead used the HOMA index for the assessment of insulin sensitivity. Second our data based on a single measurement, rather than serial measurements, must be interpreted cautiously. Thirdly since the study has cross sectional design cause and effect relationship cannot be suggested. Thirdly, our study sample was relatively small; still, we believe that because our study group was composed of special patients that included both newly diagnosed hypertensive patients without previous known cardiovascular diseases and who were not receiving any antihypertensive drugs; thus the effects of cardiovascular comorbidity and medication were potentially ruled out.
In conclusion, we suggest that although PTH and HOMA-INDEX are related with BPs, discrepancy exists regarding systolic and diastolic BPs. More studies are needed to highlight underlying mechanisms regarding PTH, insulin resistance, systolic and diastolic BPS. creatinine clearance (rho: -0.519, p<0.0001), blood urea nitrogen (rho: 0.403, p<0.0001), creatinine (rho: 0.513, p<0.0001). Of note there was no correlation between PTH and HOMA-INDEX (rho: -0.038, P: 0.723). There were also no correlations between calcium, phosphorus and BP levels in our sample. Lastly, we divided patients into 3 groups namely: i) Isolated systolic hypertension (defi ned as: SBP ≥ 140 mmHg whereas DBP <90 mmHg)
ii) Isolated diastolic hypertension (defi ned as: DBP ≥ 90 mmHg whereas SBP <140 mmHg)
iii) Both systolic and diastolic hypertension (defi ned as: DBP ≥ 90 mmHg and SBP ≥ 140 mmHg). There were 25 patients with isolated systolic hypertension, 27 patients with isolated diastolic hypertension, and 40 patients with both systolic and diastolic hypertension. Comparison of PTH and HOMA-INDEX among these 3 groups showed no statistical difference with respect to PTH (P: 0.289), and HOMA-INDEX (P: 0.242).
DISCUSSION
In the current study we demonstrated that insulin resistance as evaluated with HOMA-INDEX was associated with systolic BP but not with diastolic BP. On the other hand, serum PTH levels was associated with diastolic BP but not with systolic BP.
Regarding the insulin resistance and BPs; different mechanisms play a role in the development of hypertension. Firstly insulin may cause hypertension by increasing sympathoadrenal activity and sustained activation of the sympathetic nervous system may be involved in the development of hypertension in patients with insulin resistance (10) (11) (12) . Secondly, insulin resistance may be associated with endothelial dysfunction. Defective insulin-mediated and endothelium-dependent vasodilatation in insulin-resistant states may result in hypertension (13) . Thus our fi ndings were in accord with the previous fi ndings.
Another fi nding of the current study was the association between PTH levels and diastolic BP. Previously it has been shown that primary hyperparathyroidism has been associated with hypertension (14) (15) (16) . Multiple factors contribute to parathyroid hypertension including augmentation of renin angiotensin system (14, 17) , upregulation of the sympathetic nervous system (18), alteration of arterial tone due to impaired endothelial vasodilatory function (19) inducing renal damage and renal calculi (20) . Lastly, increased serum calcium was thought to responsible for increased HT in hyperparathyroidism. Hulter et al. administered supra physiological doses of human 1,34-PTH for 12 days to healthy subjects. The infusion of 1,34-PTH induced hypercalcemia and in parallel a signifi cant increase in blood pressure. Both hypercalcemia and hypertension normalized after the infusion was stopped (21) . However, in another study dose of PTH was chosen that induced only a minor increase in ionized calcium concentration within the normal
